Strategic Analysis of the U.S. Prenatal Testing Market


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service analyzes the market for prenatal testing with market sizing and forecasts for laboratory service revenues, which are typically reimbursed by the patient's insurance, fee-for-service, or institutional contracts. In this analysis, prenatal testing revenues include the use of clinical laboratory technologies in prenatal applications for detection of chromosomal imbalances and procedures for nuchal translucency prenatal ultrasound. Prenatal testing revenues exclude fetal anatomy ultrasound procedures, single-gene disorders and other inherited diseases, clinical prenatal lab testing using noninvasive prenatal diagnostic technologies, carrier testing, neonatal or postnatal testing, and preimplan

Table of Contents

Strategic Analysis of the U.S. Prenatal Testing Market, U.S. Prenatal Testing MarketAnalysis of the U.S. Prenatal Testing MarketResearch Service

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.